Pharmassent is experienced in implementing high-quality assessment of any project to audit and build a strong strategy to target the French market.
Pharmassent is experienced in implementing high-quality assessment of any project to audit and build a strong strategy to target the French market.
Our consultants have wide scientific background and excellent technical knowledge of regulatory affairs to suggest procedures for optimised efficiency.
You can rely on our expertise to get your products (drugs and/or medical devices) to the French market faster with an appropriate tailored solution.
Pharmassent is a consultancy firm specialized in strategic pharmaceutical business development with strong proficiency in France and Europe. By concentrating intensely on France and ANSM French pharmaceutical regulatory authorities as a gateway to all Europe, we offer the knowledge, skills and strong experience in the pharmaceutical industry to get your product to market. We offer specific and unique quality advice. We support multinational and smaller manufacturing companies. Our agency can be a very reliable and efficient partner in your product submission (drug and/or medical device), marketing authorization process, reimbursement procedures, R&D financing, drug manufacturing, product marketing and sales, fundraising, hospitals tenders or navigating regulatory issues for product approval…
Pharmassent connect investors and startups to make business and to thrive. We act as a facilitator to create a gateway between highest venture capital investments per capital and top biomedical talent to boost an innovative m-health, drug or MD project.
The Pharmassent “Relate” brand is our Special Appointment Setting Service. We search for and contact by phone relevant people for your commercial department staff dedicated to France to schedule face-to-face appointments with decision-makers in your field.
You need to finance your venture in the field of pharmaceuticals or biotechnology. Pharmassent stands by your side to search for investors, fundraising, shareholders, private participation, corporate partnerships or even government funding.
Your company created great mHealth solutions that you can offer to patients. We know how to connect health and digital business, and we know the benefits of health monitoring using apps. At Pharmassent, we help you pursue a clear development plan.
We are experienced in implementing high-quality assessment of any project to audit and build a strong strategy to target the French market. We evaluate the potential and the destination of your products (MD/Drug), and then elaborate product management plans.
Our national expertise and strong relationships with health authorities in France mean better market penetration efficiency for your product. We will help you build an essential and reliable relationship with healthcare professionals.
At Pharmassent, we promote dynamic venture synergy and partnership with top French biopharmaceutical and GMP manufacturers to help produce your ATMP (Advanced Therapy Medicinal Product) and comply with ATMP-MTI European regulation.
Pharmassent supports pharmaceutical companies through the entire process of obtaining reimbursement regulatory approval. As a result, Pharmassent can help you develop solid reimbursement strategy and analyze the environment of your drug/device.
Pharmassent provides strategic support, tailored to the client’s needs, in addressing France regulatory affairs. Our expertise in regulatory compliance and project facilitation with ANSM and HAS practice can bring improved recognition to your brand and product.
Cannabis News: In US, the first cannabinoid-based drug has been officially approved by the FDA these days. Epidiolex, the new GW Pharmaceuticals treatment…